Policy / Regulatory

NHSA Releases Official Guidelines for Drug Negotiations and Bidding for NRDL Update

CompanyDeals

Carbon Medical Technology Secures Over RMB 100 Million in Series A Financing for Interventional Therapy

CompanyDrug

BeiGene’s Tislelizumab Receives Positive CHMP Opinion for Esophageal Cancer Treatment

CompanyDrug

CanSino Biologics Granted Approval by Health Canada for Zoster Vaccine Candidate CS-2032

CompanyDeals

Bavarian Nordic’s RSV Vaccine Candidate Fails Phase III Trial, Discontinues Program

Legal / IPPolicy / Regulatory

National Health Commission Launches One-Year Anti-Corruption Campaign in Pharmaceutical Sector

Company

FDA Assures No Disruption to US Drug Supply Chain After Pfizer Warehouse Tornado

CompanyDeals

Biotherus Inc. and BioNTech SE Enter Global License Agreement for Cancer Therapies

CompanyDrug

Antengene Corp. Receives FDA Fast-Track Designation for Xpovio in Myelofibrosis Treatment

CompanyDeals

Riparian Pharmaceuticals Secures Exclusive License Agreement with Pfizer for Cardiovascular Program

CompanyDeals

Acotec Scientific and Boston Scientific Announce Comprehensive Collaboration Agreement

CompanyDrug

Hansoh Pharmaceutical’s Ibrexafungerp NDA Accepted for Review by China’s NMPA for VVC Treatment